MacroGenics Investor Relations Material
Latest events
Q4 2023
MacroGenics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from MacroGenics Inc
Access all reports
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer. Its portfolio includes R&D-stage immunotherapies to treat a range of cancers including HER2+ breast cancer, prostate cancer, lung cancer, and other indications. The company also focuses its efforts on creating antibody-based treatments for infectious diseases such as hepatitis C virus (HCV), dengue virus (DV), and acute viral respiratory infections. MacroGenics was founded in 2000 and is headquartered in Rockville, Maryland.
Key slides for MacroGenics Inc
Investor Presentation
MacroGenics Inc
Investor Presentation
MacroGenics Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States